We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Impact of a Pain Diary in Pediatric Patients

This study has been terminated.
(Poor enrollment and data collection)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00935207
First Posted: July 8, 2009
Last Update Posted: May 3, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Andrew Ostrenga, University of Mississippi Medical Center
  Purpose
The purpose of this study is to show the impact of a pain diary on the communication of pain by pediatric patients. Participants will be given a pain diary after consent and asked to complete the record each time they have pain. A survey about the efficacy of the pain diary will be taken prior to discharge by the nurse, physician, patient and parents. The hypothesis is that the pain diary will improve the communication.

Condition Intervention
Pain Other: Pediatric Pain Diary

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: The Impact of a Pain Diary on the Communication of Pain in Pediatric Patients

Further study details as provided by Andrew Ostrenga, University of Mississippi Medical Center:

Primary Outcome Measures:
  • Child Survey [ Time Frame: Hospital discharge ]
  • Parent Survey [ Time Frame: Hospital Discharge ]
  • Nurse Survey [ Time Frame: Hospital Discharge ]
  • Physician Survey [ Time Frame: Hospital Discharge ]

Enrollment: 8
Study Start Date: June 2009
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Pediatric Pain Diary
Patients will be give a pain diary to complete.
Other: Pediatric Pain Diary
Pain diary designed for pediatric patients

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   3 Years to 19 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Inpatients at the Blair E. Batson Hospital for Children 3-19 years of age, receiving regular controlled substance analgesic defined as: codeine with acetaminophen, fentanyl, hydromorphone, meperidine, morphine, oxycodone with acetaminophen, propoxyphene with acetaminophen, and hydrocodone with acetaminophen.
Criteria

Inclusion Criteria:

  • Inpatients at the Blair E. Batson Hospital for Children 3-19 years of age, receiving regular controlled substance analgesic defined as: codeine with acetaminophen, fentanyl, hydromorphone, meperidine, morphine, oxycodone with acetaminophen, propoxyphene with acetaminophen, and hydrocodone with acetaminophen.

Exclusion Criteria:

  • Admitted to the Pediatric Intensive Care Unit
  • Surgical patients, defined as patients having surgery since admission other than minor procedures
  • Patients anticipated to receive pain medication for less than 24 hours
  • Patients unable to verbally communicate their pain
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00935207


Locations
United States, Mississippi
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216
Sponsors and Collaborators
University of Mississippi Medical Center
Investigators
Principal Investigator: Andrew Ostrenga, Pharm.D. University of Mississippi Medical Center
  More Information

Responsible Party: Andrew Ostrenga, Pharmacist, University of Mississippi Medical Center
ClinicalTrials.gov Identifier: NCT00935207     History of Changes
Other Study ID Numbers: 2009-0054
First Submitted: June 17, 2009
First Posted: July 8, 2009
Last Update Posted: May 3, 2013
Last Verified: May 2013

Keywords provided by Andrew Ostrenga, University of Mississippi Medical Center:
Pain
Pediatric Pain
Pain Diary
Pediatric Pain Measurement
Pain Measurement